Peter Justin Klein

Partner, Healthcare at New Enterprise Associates

Peter Justin Klein

Peter Justin Klein

Partner, Healthcare at New Enterprise Associates

Overview
Career Highlights

Vensana Capital

RelSci Relationships

935

Number of Boards

19

Birthday

1977

Age

43

Contact Data
Trying to get in touch with Peter Justin Klein? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Peter Justin Klein likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Eximis Surgical, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Intact Vascular, Inc.

Relationship likelihood: Strong

Investor at VytronUS, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at VytronUS, Inc.

Relationship likelihood: Strong

Partner Emeritus at New Enterprise Associates

Relationship likelihood: Strong

Founder at Carticept Medical, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Senseonics Holdings, Inc.

Relationship likelihood: Strong

Founder at Quaker Partners Management LP

Relationship likelihood: Strong

Former Managing Member at Delphi Management Partners VII LLC

Relationship likelihood: Strong

Chief Financial Officer at Avita Medical Ltd.

Relationship likelihood: Strong

Paths to Peter Justin Klein
Potential Connections via
Relationship Science
You
Peter Justin Klein
Partner, Healthcare at New Enterprise Associates
Career History
Partner, Healthcare
2006 - Current

New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.

Investor
Current

VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA.

Co-Founder & Managing Partner
Tenure Unconfirmed
Boards & Committees
Member, Compensation Committee
2015 - Current
Director
Prior
Member, Board of Directors
Prior
Member, Board of Trustees
Prior
Member of the Institutional Review Board
Prior
Political Donations
$450
2012
Transactions
Details Hidden

Wright Medical Group Inc., Wright Medical Group NV purchase Cartiva, Inc. from Alta Partners Management Corp., New Enterprise Associates, Windham Venture Partners

Details Hidden

ASN Technologies, Inc. purchases Senseonics, Inc. from HealthCare Ventures LLC, Abingworth LLP, Rho Ventures, New Enterprise Associates, Anthem Capital Management LLC, Roche Ventures

Investments
Details Hidden

Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC.

Details Hidden

VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Peter Justin Klein. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Peter Justin Klein's profile does not indicate a business or promotional relationship of any kind between RelSci and Peter Justin Klein.